Table 1 Clinical and procedural characteristics for 124 patients who underwent TAVI
Control group (n. 62) | Study group (n.62) | p-Value | |
|---|---|---|---|
Age, years | 79.92 ± 7.79 | 79.61 ± 5.46 | 0.93 |
Body mass index | 26.9 ± 5.32 | 28.3 ± 5.49 | 0.98 |
Female gender | 53.2 % | 64.5 % | 0.21 |
Rhythm | |||
Sinus | 66.1 % | 61.3 % | 0.56 |
Atrial fibrillation | 25.8 % | 35.5 % | 0.24 |
Pace maker | 8.1 % | 3.2 % | 0.22 |
Coronary Heart Disease | 72.6 % | 71.7 % | 0.9 |
Peripheral artery disease | 36.5 % | 21 % | 0.06 |
Previous myocardial infarction | 17.5 % | 12.9 % | 0.39 |
Pre-Aortic regurgitation | |||
No | 27.0 % | 27.9 % | 0.9 |
Mild | 63.5 % | 47.9 % | 0.09 |
Moderate | 9.5 % | 24.2 % | 0.02 |
Valve size | |||
26 mm | 42 % (26) | 48.4 % (30) | 0.5 |
29 mm | 51.6 % (32) | 46.7 % (29) | 0.6 |
31 mm | 3.3 % (4) | 4.9 % (3) | 0.6 |
Mitral regurgitation | |||
No | 9.5 % | 19.7 % | 0.11 |
Mild | 71.4 % | 52.5 % | 0.03 |
Moderate | 17.5 % | 26.2 % | 0.22 |
Severe | 1.6 % | 1.6 % | 1 |
EF, % | 45.6 ± 15.89 | 38.9 ± 12.77 | 0.01 |
Aortic valve area, cm2 | 0.7 ± 0.18 | 0.68 ± 0.17 | 0.57 |
Peak pressure gradient, mmHg | 70.19 ± 25.15 | 71.54 ± 25.3 | 0.81 |
Mean pressure gradient, mmHg | 45.9 ± 17.67 | 45.69 ± 17.77 | 0.94 |
Annulus, mm | 23.28 ± 1.7 | 21.58 ± 1.6 | 0.25 |